Brand check
Is Disprin banned in India?
Last checked 19 September 2026
Disprin and other single-ingredient aspirin products are not banned in India as of 19 Sep 2026; the only aspirin-related prohibition is the aspirin + ethoheptazine FDC under S.O. 3068(E) of 11 Jun 2026.
- Classification
- No ban or recall found in official records
- Decided by
- CDSCO / Ministry of Health and Family Welfare
- Reference
- No Section 26A notification for aspirin; S.O. 3068(E), 11 Jun 2026, covers aspirin + ethoheptazine only
- Latest action
- 11 June 2026
- Last checked
- 19 September 2026
Enteric-coated aspirin tablets. Photo: Regular strength enteric coated aspirin tablets.jpg by Ragesoss (CC BY-SA 4.0). Brand names and logos belong to their owners and are used here to identify the product this entry is about. All photo credits.
CDSCO: Drugs banned in India (consumer section)
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- Governing authority
- CDSCO, Ministry of Health and Family Welfare
- Ban notification
- None for aspirin alone
- Related FDC ban
- Acetylsalicylic acid + ethoheptazine, S.O. 3068(E), 11 Jun 2026
- Marketer
- Reckitt (Disprin); USV (Ecosprin)
- Children
- Aspirin is avoided in children with viral fever (Reye's syndrome), a clinical caution, not a ban
Where the claim comes from
The 16-FDC notification of 11 June 2026 began with 'acetylsalicylic acid + ethoheptazine' as S.O. 3068(E). Lists that shortened this to 'aspirin banned' produced a spike in 'is Disprin banned' and 'is aspirin banned in India' searches. The long-standing advice against aspirin in children with viral fevers is sometimes also described as a ban.
Disprin is a soluble aspirin tablet and one of the oldest painkiller brands in India. Aspirin is also used in low doses to prevent heart attacks and strokes under brands such as Ecosprin. None of this is banned.
The trigger for the question was the Health Ministry's notification of 11 June 2026 prohibiting 16 fixed-dose combinations. The first entry, S.O. 3068(E), is acetylsalicylic acid with ethoheptazine, an old analgesic pairing that had little modern use. Because "acetylsalicylic acid" is the chemical name for aspirin, summaries of the list read "aspirin combination banned" and then, in shorter form, "aspirin banned". The order applies only to that combination.
Single-ingredient aspirin has never been notified under Section 26A. It appears in the National List of Essential Medicines for cardiovascular use, and Disprin, Ecosprin and their generics are licensed.
A separate point often folded into the question: doctors avoid aspirin in children and teenagers with viral illnesses because of the risk of Reye's syndrome. That is a prescribing caution found in the product label, not a regulatory prohibition.
If you take aspirin daily on a doctor's advice, the June 2026 order changes nothing. If you have an old pain tablet whose label mentions ethoheptazine, ask your pharmacist about disposal.
What this means for you
Disprin and Ecosprin are unaffected
Both are single-ingredient aspirin and remain on sale.
Check old pain combinations
A product listing ethoheptazine alongside aspirin should no longer be dispensed after June 2026.
Low-dose aspirin for the heart continues
Do not change a cardiologist-prescribed aspirin dose on the basis of a headline.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Batches flagged in CDSCO alerts
Products whose name matches this brand or molecule in CDSCO monthly NSQ alerts. A flagged batch is a single batch; the company's response, where reported, is noted on the page above.
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Clopidogrel & Aspirin Tablets IP | P0825176TMfg 2025-08 · Exp 2027-07 | Pharmaroots HealthcareHimachal Pradesh | Dissolution, Free Salicylic Acid, Content of Clopidogrel (38.20%) and Aspirin (21.8%)Dissolution | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Clopidogrel & Aspirin Tablets | TSF-C2763Mfg 2024-10 · Exp 2026-09 | Spen Formulations Pvt. Ltd | DescriptionDescription | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Clopidogrel & Aspirin Tablets | GT31923CMfg 2026-02 · Exp 2028-01 | J.M.LaboratoriesHimachal Pradesh | Free salicylic Acid (12.01%) and Content of Aspirin (77.13%)Other | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| ASPIRIN TABLET IP 75MG | 240968Mfg 2024-09 · Exp 2027-08 | MODI ANTIBIOTICS Plot No-28 G.I.D.C. Estate Odhav Ahmedabad 382415Gujarat | l]five (5) intact strips often (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2. The content of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling | FDAL, MumbaiState lab | Jul 2026 |
| ASPIRIN TABLET IP 75MG | 250168Mfg 2025-01 · Exp 2027-12 | MODI ANTIBIOTICS Plot No-28 G.I.D.C. Estate Odhav Ahmedabad 382415Gujarat | 1. five (5) intact strips of ten (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2 The co tent of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling | FDAL, MumbaiState lab | Jul 2026 |
| ASPIRIN GASTRO- RESISTANT TABLETS I.P. 75 MG | CBT-0254Mfg 2025-10 · Exp 2027-09 | Crossasia Biotech Pvt. Ltd. Survery No. 488 A.B. Road Girwai industrial Area Beldarpura Gwalior 474002 (M.P) | Description test for Salicylic Acid Assay for Aspirin and test for DissolutionAssay | RDTL. Bellary KarnatakaState lab | Jul 2026 |
| Rosuvastatin, Aspirin and Clopidogrel Capsules | SIBP25509Mfg 2025-08 · Exp 2027-07 | Bioaltus Pharmaceuticals Pvt. LtdSikkim | The sample does not conform to the claim with respect to Assay of Rosuvastatin and Aspirin.Assay | DTL JaipurState lab | May 2026 |
| Clopidogrel and Aspirin Capsules | ND260242Mfg 2026-01 · Exp 2027-12 | Nanoceut Therapeutics Pvt. LtdPuducherry | Free Salicylic acidOther | DTL, Chennai-06State lab | May 2026 |
| Aspirin Gastro-resistant and Atorvastatin Capsules IP (75mg/10mg) | AAC5053Mfg 2025-07 · Exp 2027-06 | Vivimed Labs LimitedTelangana | The sample does not conforms to I.P.2022 with respect to the Test for Related substances for Aspirin and Atorvastatin.Related substances | CDTL, MumbaiCDSCO lab | May 2026 |
| Aspirin Gastro-resistant Tablets IP 75 mg | ANET1273Mfg 2024-10 · Exp 2026-09 | Unicure India LimitedUttar Pradesh | Dissolution, Salicylic Acid and Assay as per IPAssay | DTL KonniState lab | May 2026 |
| Aspirin Gastro-resistant Tablets IP 75 mg | ANET1283Mfg 2024-10 · Exp 2026-09 | Unicure India LtdUttar Pradesh | Dissolution, Salicylic Acid and AssayAssay | DTL ThrissurState lab | May 2026 |
| Aspirin Gastro-Resistant Tablets IP 75mg | ANET1243Mfg 2024-05 · Exp 2026-04 | Unicure India LtdUttar Pradesh | The Sample fails the test 'Descriptive Part, Dissolution, Salicylic Acid and Assay as per IPAssay | DTL ThiruvananthapuramState lab | Apr 2026 |
| Aspirin Gastro-Resistant Tablets IP 150 mg | ASB07J24Mfg 2024-10 · Exp 2026-09 | Bajaj Healthcare LtdGujarat | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab | Mar 2026 |
| Dispersible Aspirin Tablets | T-6705Mfg 2025-07 · Exp 2027-06 | Jackson Laboratories Pvt.Ltd. 22-24Punjab | The sample is not of standard quality for the reason stated under Description of the tablets.Description | RDTL, GuwahatiCDSCO lab | Feb 2026 |
| Atorvastatin, Aspirin & Clopidogrel Capsules s | ADH24148AMfg 2024-10 · Exp 2026-09 | Astonea Labs Private LimitedHaryana | Test free Salycylic AcidOther | MaharashtraState lab | Feb 2026 |
| Aspirin Gastro-resistant Tablets IP 75 mg. | ANET1295Mfg 2024-12 · Exp 2026-11 | Unicure India Ltd. C-21Uttar Pradesh | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution in Acid stage for Aspirin.Dissolution | RDTL, GuwahatiCDSCO lab | Feb 2026 |
| Aspirin Gastro-resistant Tablets IP 75 mg. | ANET1295Mfg 2024-12 · Exp 2026-11 | Unicure India LtdUttar Pradesh | The sample does not conform to I.P.w.r.t. the tests for Dissolution in Acid Stage for Aspirin.Dissolution | RDTL, GuwahatiState lab | Feb 2026 |
| Aspirin Gastro-Resistant Tablets IP 150 mg | ASB02B25Mfg 2025-02 · Exp 2027-01 | Bajaj Healthcare Ltd. R.S. No. 1818 | Rough Surface on Tablets DescriptionDescription | FDTL,UttarakhandState lab | Feb 2026 |
| Aspirin Gastro Resistant Tablets IP 75mg | ANET 1269Mfg 2024-10 · Exp 2026-09 | Unicure India LtdUttar Pradesh | Sample fails the test Dissolution' as per IP as specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab | Feb 2026 |
| Clopidogrel & Aspirin Tablets IP | GT250518Mfg 2025-03 · Exp 2027-02 | Theon Pharmaceuticals Ltd. Vill. Saini MajraHimachal Pradesh | The sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Description And Test For Free Salicylic Acid Only.Description | CDTL-HyderabadCDSCO lab | Dec 2025 |
Official sources and primary records
- Medical Dialogues: Health ministry bans 16 FDCs including amoxicillin + serratiopeptidase, full listNewsMedical Dialogues
- Business Standard: Centre bans sale, manufacture of 16 FDC drugs over public health concernsNewsBusiness Standard · 20 June 2026
- Regulator